Part II: NP/PA 16-Hour Waiver Training

4.69 (175 votes)

Recorded On: 12/10/2015


Back to Package

  • Registration Closed

image

The 16-hour product developed includes all additional education required by the Comprehensive Addiction and Recovery Act (CARA) for nurse practitioners to successfully apply for a waiver to prescribe buprenorphine for office-based treatment of opioid use disorders.

Click the "Content" tab to get started!

Tricia Wright

MD, MS, FACOG, FASAM

Tricia Wright, MD MS is an assistant professor of Obstetrics, Gynecology and Women's Health at the University of Hawaii John A. Burns School of Medicine and founder, former medical director, and now Women's Health Liaison of the PATH Clinic, an outreach clinic of Waikiki Health Center, which provides prenatal, postpartum and family planning to women with a history of substance use disorders. She is board certified in both Ob/Gyn and Addiction Medicine and a Fellow of the American College of Obstetrics and Gynecology. She has been waivered to provide buprenorphine since 2009, and has treated both pregnant and non-pregnant women. She won funding approval in 2006 from the Hawaii legislature to start a perinatal clinic for women with substance use, the first in the state. The Path Clinic opened in 2007, and has seen over 400 pregnant women since that time. She completed her Masters Degree in Clinical Research from the University of Hawaii in 2009, her thesis paper studying the disparities of smoking and drug use rates during pregnancy of Native Hawaiian women. Her research interests include substance use disorders among pregnant women, including barriers to family planning, screening, brief intervention and referral to treatment (SBIRT), best practices for treatment, and the effects of methamphetamine, marijuana and tobacco on the placenta.

Timothy K. Brennan

MD, MPH, FASAM

Timothy Brennan, MD, MPH, FASAM is an Addiction Medicine physician and Pediatrician. He is the Director of the Addiction Institute at Mount Sinai West and St. Luke's Hospitals in New York City and the Vice President for Medical and Academic Affairs at The Addiction Medicine Foundation. He is also the Director of the Fellowship in Addiction Medicine at the Icahn School of Medicine at Mount Sinai. He completed a Fellowship in Addiction Medicine at the Addiction Institute of New York, a Fellowship in Medical Ethics at Harvard Medical School, a Residency in Pediatrics at Weill Cornell Medical College / New York Presbyterian Hospital, and an Internship in Internal Medicine at Georgetown University Hospital. He is the Co-Editor of Essentials of Addiction Medicine and Board Certified in Addiction Medicine and Pediatrics.

Brian Hurley

MD, MBA, DFASAM

Los Angeles Country Department of Health Services

Brian Hurley, MD, MBA, DFASAM is an addiction physician and the Director of Addiction Medicine for the Los Angeles County Department of Health Services. As Director-at-Large, Brian currently serves as a board member of ASAM and gives presentations around the world regarding addiction medicine. He co-chairs the Los Angeles County Department of Health Services’ Substance Use Disorders Workgroup and the SafeMedLA Medications for Addiction Treatment Action Team, and is the Clinical Director of the Treatment Starts Here program through the Center for Clinical Innovation, focused on increasing the delivery of medications for addiction treatment in California’s community health centers. 

He is a senior researcher at the Friends Research Institute and is a primary investigator on a Tobacco Related Disease Prevention Program-funded project integrating smoking cessation services into community mental health centers and patient-centered medical homes and is the grant lead for three Medications for Addiction Treatment Access Points projects funded by the Sierra Health Foundation supporting access to medications for addiction treatment across Los Angeles County. 

He is also a co-investigator for several Rand Corporation projects evaluating the integration of substance use disorder treatment within community mental health and Federally Qualified Health Center settings. He also serves on the American Board of Psychiatry and Neurology’s Addiction Psychiatry Examination Writing Committee. Brian completed the Robert Wood Johnson Foundation Clinical Scholars Program at the University of California, Los Angeles (UCLA) and is an alumnus of the Massachusetts General Hospital and McLean Hospital Psychiatry Residency Training Program and the New York University Addiction Psychiatry Fellowship. Additionally, he has served in various roles for the Massachusetts Society of Addiction Medicine, New York Society of Addiction Medicine, and California Society of Addiction Medicine.

No Relevant Financial Disclosures 

The collaborative of ASAM, AANP and AAPA identified and reviewed this content to provide the NP/PA training required by CARA.

The NP/PA 24-Hour Waiver Training is available for free through 2017 in part by an unrestricted educational grant from Indivior.

The 16-hour product developed includes all additional education required by the Comprehensive Addiction and Recovery Act (CARA) for nurse practitioners to successfully apply for a waiver to prescribe buprenorphine for office-based treatment of opioid use disorders.

Download this helpful FAQ for technical issues.

All other questions, contact ASAM Education.
education@ASAM.org | 301.656.3920

Upon successful completion of all 16 hours, return to the AANP CE Center to submit an evaluation and claim credit.

Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs and PAs from prescribing these medications even if Federal law allows it.

Apply

SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

Qualify 

To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must: 

  • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
  • Complete no less than 24 hours of appropriate education through a qualified provider or through other training or experience, demonstrate the ability to treat and manage OUD
  • If required by state law, supervision or working in collaboration with a qualifying physician (physician must be waivered) to prescribe medications for the treatment of OUD may be required.
  •   

Key:

Complete
Failed
Available
Locked
Opioid Maintenance and Detoxification
The ASAM National Practice Guideline on Medications to Treat Opioid Use Webinar
Open to view video.
Open to view video. Webinar recorded on December 10, 2015 by Margaret Jarvis, MD, DFASAM.
Test 1.1
5 Questions  |  10 attempts  |  3/5 points to pass
5 Questions  |  10 attempts  |  3/5 points to pass Test
The ASAM National Practice Guideline Special Populations Webinar (Pregnant Women)
Select the "View On-Demand Recording" button to begin.  |  45 minutes
Select the "View On-Demand Recording" button to begin.  |  45 minutes This webinar is live on July 26, 2016 at 12:00 pm EST. You can log in up to 15 minutes early.
Test 1.2
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Test
Clinical Use of all FDA-Approved Drugs for MAT
Alcohol
Open to view video.
Open to view video. 53 Minutes
Test 2.1
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Test
Opioids
Open to view video.
Open to view video. 60 Minutes
Test 2.2
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Test
Tobacco
Open to view video.
Open to view video. Audio-Synced Slides
Test 2.3
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Quiz to Claim Credit
Safe & Effective Use of Medication-Assisted Treatment: Tools for Providers
Open to view video.
Open to view video. This presentation was given on April 16, 2016, at The ASAM 47th Annual Conference.
Test 2.4
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Complete this quiz to receive CME for this presentation.
Novel Pharmacological Targets for Treating Alcohol Use Disorder
Open to view video.
Open to view video. Recorded on Saturday, October 8, 2016.
Developing Pharmacological Treatments for Alcohol Use Disorder: Implications for Clinical Practice
Open to view video.
Open to view video. Recorded on Saturday, October 8, 2016.
Opioid Abuse Treatment: New Forms and Delivery Systems for Buprenorphine
Open to view video.
Open to view video. Recorded on Saturday, October 8, 2016.
Test 2.5
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Complete the quiz to claim CME Credit.
Patient Assessment
Definitions, the ASAM Criteria and the DSM-5
Open to view video.
Open to view video. Audio-Synced Slides
Test 3.1
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Quiz to Claim Credit
Principles of Pharmacology and Toxicology
Open to view video.
Open to view video. Audio-Synced Slides
Test 3.2
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Quiz to Claim Credit
Treatment Planning
Medical Co-Morbidities
Recorded 04/06/2016
Recorded 04/06/2016 Self-paced online module.
Test 4.1
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Test
Individuals with Co-Occurring Psychiatric Disorders
Select the "View On-Demand Recording" button to begin.  |  45 minutes
Select the "View On-Demand Recording" button to begin.  |  45 minutes This webinar was presented on June 21, 2016 by Brian Hurley, MD, MBA, DFASAM.
Test 4.2
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Test
The ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
Open to view video.
Open to view video. Recorded on Thursday, October 6, 2016.
HHS Opioid Initiative
Open to view video.
Open to view video. Recorded on Thursday, October 6, 2016.
Guidelines on Treating Substance Use Disorders During Pregnancy
Open to view video.
Open to view video. Recorded on Thursday, October 6, 2016.
Test 4.3
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Complete the quiz to claim CME Credit.
The Epidemiology of Prescription Opioid Abuse and the Recent Transition to Heroin
Open to view video.
Open to view video. Recorded on Thursday, October 6, 2016.
CDC Guideline for Prescribing Opioids for Chronic Pain
Open to view video.
Open to view video. Recorded on Thursday, October 6, 2016.
Opioid Therapy for Chronic Pain in the United States: Promises and Perils
Open to view video.
Open to view video. Recorded on Thursday, October 6, 2016.
Treating Women for Opioid Use Disorders During Pregnancy: The Latest Research
Open to view video.
Open to view video. Recorded on Thursday, October 6, 2016.
Test 4.4
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Complete the quiz to claim CME Credit.
Psychosocial Services
Cognitive Behavior Therapy & Motivational Interviewing
Open to view video.
Open to view video. Audio-Synced Slides
Test 5.1
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Quiz to Claim Credit
12-Step Facilitation and Other Psychosocial Interventions
Open to view video.
Open to view video. 60 MInutes
Test 5.2
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Test
Verification
AANP Participation Code
Agree to terms to continue.
Agree to terms to continue. In order to claim credit in the AANP CE Center, you must input the Participation Code.
Return to AANP CE Center
Select the "Return to AANP CE Center" button to begin.
Select the "Return to AANP CE Center" button to begin. Click here to return to AANP's CE Center, where you can submit an evaluation and claim credit for this course.